Company: WHWK
Filing Date: 2025-01-31
Form Type: DEFM14A
Source: 0001193125-25-018470
Chunk: 472

Company: Whitehawk Therapeutics, Inc.
Filing Date: 2025-01-31
Form: DEFM14A
Chunk 472
---
KVP                                                                                                                                                
 Capital”); (ii) 19,694 shares of common stock held directly by Dr. Castelein, (iii) 499,998 shares of common stock held indirectly by KVP Capital and (iv) 71,895 shares of common stock issuable upon the exercise of options within 60 days 
 of January 30, 2025. Dr. Castelein is the Managing Director of KVP Capital and Dr. Castelein disclaims beneficial ownership of the shares held by KVP Capital, except to the extent of his pecuniary interest therein.                        |

| (13) | Consists of (i) the securities listed in footnote (1) above and (ii) 64,377 shares of common stock 
 issuable upon the exercise of options within 60 days of January 30, 2025.                          |

| (14) | Consists of (i) 1,130 shares of common stock held directly by Dr. Dalal; (ii) the securities listed                                      
 in footnote (2) above, and (iii) 71,895 shares of common stock issuable upon the exercise of options within 60 days of January 30, 2025. |

| (15) | Consists of 63,314 shares of common stock issuable upon the exercise of options within 60 days of 
 January 30, 2025.                                                                                 |

| (16) | Consists of 40,103 shares of common stock issuable upon the exercise of options within 60 days of 
 January 30, 2025.                                                                                 |

| (17) | Consists of 88,167 shares of common stock issuable upon the exercise of options within 60 days of 
 January 30, 2025.                                                                                 |

| (18) | Consists of 63,314 shares of common stock issuable upon the exercise of options within 60 days of 
 January 30, 2025.                                                                                 |

| (19) | Consists of (i) 833,000 shares to be purchased in the PIPE Offering by WZCUBE LLC; and (ii) 5,099 shares                                                                                                                                       
 of common stock issuable upon the exercise of options within 60 days of January 30, 2025. Baiteng Zhao is the manager of WZCUBE LLC and exercises investment and voting power over the shares held. Dr. Zhao disclaims beneficial ownership of 
 the shares held by W